Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 31 | 2021 | 1292 | 3.640 |
Why?
|
| Extracorporeal Membrane Oxygenation | 12 | 2022 | 1483 | 2.280 |
Why?
|
| Shock, Cardiogenic | 6 | 2021 | 711 | 1.800 |
Why?
|
| Intra-Aortic Balloon Pumping | 3 | 2021 | 223 | 1.340 |
Why?
|
| Heart Transplantation | 11 | 2022 | 3301 | 1.300 |
Why?
|
| Mitral Valve | 18 | 2020 | 1475 | 1.250 |
Why?
|
| Heart Ventricles | 10 | 2021 | 3841 | 1.070 |
Why?
|
| Heart Valve Prosthesis Implantation | 6 | 2020 | 1566 | 0.860 |
Why?
|
| Ventricular Function, Left | 7 | 2021 | 3941 | 0.800 |
Why?
|
| Aortic Valve Insufficiency | 3 | 2020 | 577 | 0.770 |
Why?
|
| Heart Failure | 21 | 2021 | 11879 | 0.760 |
Why?
|
| Myocardial Contraction | 7 | 2011 | 1526 | 0.730 |
Why?
|
| Sternotomy | 2 | 2018 | 132 | 0.640 |
Why?
|
| Mitral Valve Insufficiency | 11 | 2021 | 1415 | 0.530 |
Why?
|
| Prosthesis Failure | 4 | 2019 | 1208 | 0.500 |
Why?
|
| Papillary Muscles | 4 | 2011 | 192 | 0.480 |
Why?
|
| Sheep | 21 | 2015 | 1451 | 0.470 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2016 | 285 | 0.450 |
Why?
|
| Propensity Score | 3 | 2020 | 1969 | 0.440 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 642 | 0.410 |
Why?
|
| Models, Cardiovascular | 5 | 2012 | 981 | 0.410 |
Why?
|
| Thrombosis | 7 | 2018 | 2957 | 0.400 |
Why?
|
| Aortic Valve | 3 | 2020 | 1970 | 0.380 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 1942 | 0.360 |
Why?
|
| Aortic Aneurysm | 2 | 2017 | 649 | 0.360 |
Why?
|
| Finite Element Analysis | 5 | 2011 | 442 | 0.340 |
Why?
|
| Prosthesis Design | 6 | 2020 | 2125 | 0.340 |
Why?
|
| Combined Modality Therapy | 2 | 2021 | 8542 | 0.330 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2017 | 3684 | 0.300 |
Why?
|
| Retrospective Studies | 24 | 2022 | 81760 | 0.280 |
Why?
|
| Catheterization | 2 | 2022 | 1430 | 0.260 |
Why?
|
| Subclavian Steal Syndrome | 1 | 2005 | 20 | 0.250 |
Why?
|
| Treatment Outcome | 22 | 2021 | 65379 | 0.230 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 2057 | 0.230 |
Why?
|
| Aorta, Thoracic | 1 | 2010 | 1112 | 0.220 |
Why?
|
| Prosthesis Implantation | 2 | 2020 | 594 | 0.220 |
Why?
|
| Takayasu Arteritis | 1 | 2005 | 106 | 0.220 |
Why?
|
| Adaptation, Physiological | 2 | 2009 | 1312 | 0.210 |
Why?
|
| Heart Valve Diseases | 1 | 2010 | 1030 | 0.210 |
Why?
|
| Fluoroscopy | 7 | 2011 | 947 | 0.210 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2010 | 1459 | 0.200 |
Why?
|
| Tantalum | 3 | 2011 | 54 | 0.200 |
Why?
|
| Myocardial Ischemia | 4 | 2021 | 2138 | 0.200 |
Why?
|
| Tissue and Organ Procurement | 2 | 2021 | 986 | 0.190 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2019 | 646 | 0.190 |
Why?
|
| Lung Transplantation | 2 | 2021 | 1309 | 0.180 |
Why?
|
| Middle Aged | 32 | 2021 | 223487 | 0.180 |
Why?
|
| Ventricular Dysfunction, Left | 5 | 2018 | 2145 | 0.170 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2021 | 145 | 0.170 |
Why?
|
| Echocardiography | 5 | 2020 | 5047 | 0.170 |
Why?
|
| Hemodynamics | 9 | 2015 | 4194 | 0.160 |
Why?
|
| Elasticity | 3 | 2011 | 657 | 0.160 |
Why?
|
| Thoracotomy | 1 | 2020 | 374 | 0.160 |
Why?
|
| Humans | 51 | 2022 | 768171 | 0.150 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2019 | 103 | 0.150 |
Why?
|
| Female | 34 | 2021 | 397187 | 0.150 |
Why?
|
| Male | 40 | 2021 | 364731 | 0.150 |
Why?
|
| Aged | 25 | 2021 | 171502 | 0.150 |
Why?
|
| Technetium | 1 | 2018 | 328 | 0.140 |
Why?
|
| Adult | 27 | 2022 | 223646 | 0.140 |
Why?
|
| Systole | 6 | 2010 | 937 | 0.140 |
Why?
|
| Reoperation | 4 | 2020 | 4329 | 0.140 |
Why?
|
| Arteries | 1 | 2022 | 1127 | 0.140 |
Why?
|
| Postoperative Complications | 5 | 2021 | 15833 | 0.140 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2017 | 277 | 0.130 |
Why?
|
| Acidosis | 1 | 2017 | 271 | 0.130 |
Why?
|
| Electric Stimulation | 2 | 2012 | 1741 | 0.130 |
Why?
|
| Staining and Labeling | 2 | 2018 | 1080 | 0.120 |
Why?
|
| Bronchitis | 1 | 2016 | 194 | 0.120 |
Why?
|
| Oxygenators, Membrane | 1 | 2015 | 57 | 0.120 |
Why?
|
| Fibrin | 1 | 2018 | 514 | 0.120 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2016 | 133 | 0.120 |
Why?
|
| Hospital Costs | 1 | 2021 | 957 | 0.120 |
Why?
|
| Foreign-Body Migration | 1 | 2016 | 220 | 0.120 |
Why?
|
| Abdominal Wall | 1 | 2016 | 166 | 0.120 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2011 | 1243 | 0.110 |
Why?
|
| Registries | 3 | 2021 | 8375 | 0.110 |
Why?
|
| Time Factors | 11 | 2020 | 40220 | 0.110 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 845 | 0.110 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2014 | 51 | 0.110 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2014 | 193 | 0.110 |
Why?
|
| Diastole | 3 | 2009 | 785 | 0.100 |
Why?
|
| Intention to Treat Analysis | 3 | 2019 | 416 | 0.100 |
Why?
|
| Abdominal Injuries | 1 | 2016 | 362 | 0.100 |
Why?
|
| Aortic Valve Stenosis | 1 | 2005 | 2032 | 0.100 |
Why?
|
| Proportional Hazards Models | 3 | 2021 | 12543 | 0.100 |
Why?
|
| Withholding Treatment | 1 | 2016 | 620 | 0.100 |
Why?
|
| Follow-Up Studies | 6 | 2020 | 39354 | 0.100 |
Why?
|
| Myocardial Revascularization | 1 | 2016 | 795 | 0.100 |
Why?
|
| Myocardium | 2 | 2018 | 4790 | 0.100 |
Why?
|
| Models, Animal | 4 | 2015 | 2122 | 0.100 |
Why?
|
| Databases, Factual | 4 | 2021 | 8080 | 0.100 |
Why?
|
| Heart | 3 | 2010 | 4446 | 0.100 |
Why?
|
| Excitation Contraction Coupling | 1 | 2011 | 25 | 0.100 |
Why?
|
| Parasympathetic Nervous System | 1 | 2012 | 144 | 0.100 |
Why?
|
| Abdomen | 1 | 2017 | 1136 | 0.090 |
Why?
|
| Extracellular Matrix | 3 | 2015 | 1738 | 0.090 |
Why?
|
| Video Recording | 3 | 2011 | 976 | 0.090 |
Why?
|
| Preoperative Care | 1 | 2020 | 2258 | 0.090 |
Why?
|
| Hemolysis | 1 | 2013 | 417 | 0.090 |
Why?
|
| Stress, Mechanical | 3 | 2011 | 1680 | 0.090 |
Why?
|
| Coronary Artery Bypass | 1 | 2020 | 2191 | 0.090 |
Why?
|
| Survival Rate | 3 | 2021 | 12840 | 0.090 |
Why?
|
| Ventricular Pressure | 1 | 2011 | 210 | 0.090 |
Why?
|
| Graft Survival | 1 | 2021 | 3887 | 0.090 |
Why?
|
| Pulmonary Artery | 1 | 2019 | 1946 | 0.090 |
Why?
|
| Sheep, Domestic | 1 | 2009 | 52 | 0.080 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2014 | 362 | 0.080 |
Why?
|
| Vagus Nerve | 1 | 2012 | 459 | 0.080 |
Why?
|
| Hospital Mortality | 2 | 2020 | 5349 | 0.080 |
Why?
|
| Torsion, Mechanical | 1 | 2009 | 15 | 0.080 |
Why?
|
| Hypovolemia | 1 | 2009 | 48 | 0.080 |
Why?
|
| Ischemia | 1 | 2017 | 1900 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 1 | 2017 | 1508 | 0.080 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 1546 | 0.080 |
Why?
|
| Propanolamines | 1 | 2009 | 164 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 6512 | 0.070 |
Why?
|
| Risk Factors | 6 | 2021 | 74944 | 0.070 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 2008 | 0.070 |
Why?
|
| Animals | 23 | 2018 | 169285 | 0.070 |
Why?
|
| Incidence | 3 | 2021 | 21538 | 0.070 |
Why?
|
| Stroke | 6 | 2019 | 9755 | 0.070 |
Why?
|
| Atrial Fibrillation | 1 | 2006 | 5176 | 0.070 |
Why?
|
| Respiratory Insufficiency | 1 | 2016 | 1240 | 0.070 |
Why?
|
| Graft Rejection | 1 | 2020 | 4492 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2019 | 6525 | 0.070 |
Why?
|
| Pancreatitis | 1 | 2013 | 1087 | 0.070 |
Why?
|
| Equipment Failure | 2 | 2020 | 585 | 0.060 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 59626 | 0.060 |
Why?
|
| Disease Progression | 2 | 2020 | 13668 | 0.060 |
Why?
|
| Risk Assessment | 4 | 2020 | 24318 | 0.060 |
Why?
|
| Muscle, Smooth | 1 | 2009 | 931 | 0.060 |
Why?
|
| Wound Healing | 1 | 2015 | 2815 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2020 | 4858 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2009 | 4064 | 0.060 |
Why?
|
| Mitral Valve Stenosis | 1 | 2006 | 342 | 0.060 |
Why?
|
| Collagen | 2 | 2009 | 2645 | 0.060 |
Why?
|
| Ventricular Remodeling | 2 | 2008 | 1282 | 0.060 |
Why?
|
| Macrophages | 1 | 2018 | 5802 | 0.050 |
Why?
|
| Stroke Volume | 3 | 2011 | 5622 | 0.050 |
Why?
|
| Aorta, Abdominal | 1 | 2005 | 627 | 0.050 |
Why?
|
| Epidemiologic Methods | 1 | 2006 | 1328 | 0.050 |
Why?
|
| Acute Disease | 4 | 2016 | 7243 | 0.050 |
Why?
|
| Survival Analysis | 3 | 2020 | 10099 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6229 | 0.050 |
Why?
|
| Heart Valve Prosthesis | 1 | 2009 | 1468 | 0.040 |
Why?
|
| Regional Blood Flow | 2 | 2017 | 1500 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 5367 | 0.040 |
Why?
|
| Tissue Donors | 2 | 2021 | 2381 | 0.040 |
Why?
|
| Coronary Artery Disease | 2 | 2020 | 6568 | 0.040 |
Why?
|
| Elastic Modulus | 2 | 2012 | 211 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2011 | 2815 | 0.040 |
Why?
|
| Microscopy, Video | 2 | 2011 | 241 | 0.040 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 15949 | 0.040 |
Why?
|
| Triiodothyronine | 1 | 2021 | 492 | 0.040 |
Why?
|
| Hypertension | 2 | 2020 | 8616 | 0.040 |
Why?
|
| Smoking | 1 | 2016 | 9092 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 20762 | 0.040 |
Why?
|
| Learning Curve | 1 | 2020 | 232 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2005 | 1429 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2015 | 835 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2021 | 994 | 0.040 |
Why?
|
| Brain Death | 1 | 2021 | 359 | 0.040 |
Why?
|
| Models, Anatomic | 2 | 2011 | 680 | 0.040 |
Why?
|
| Disease-Free Survival | 2 | 2019 | 6847 | 0.040 |
Why?
|
| Receptors, CCR2 | 1 | 2018 | 216 | 0.040 |
Why?
|
| Thyroxine | 1 | 2021 | 665 | 0.030 |
Why?
|
| Age Factors | 3 | 2020 | 18415 | 0.030 |
Why?
|
| Acid-Base Equilibrium | 1 | 2017 | 180 | 0.030 |
Why?
|
| Anisotropy | 2 | 2011 | 1292 | 0.030 |
Why?
|
| Half-Life | 1 | 2018 | 651 | 0.030 |
Why?
|
| Asthma | 1 | 2016 | 6291 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2021 | 779 | 0.030 |
Why?
|
| Missouri | 1 | 2016 | 113 | 0.030 |
Why?
|
| Mediastinitis | 1 | 2016 | 49 | 0.030 |
Why?
|
| Weight-Bearing | 1 | 2018 | 534 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2020 | 905 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2020 | 12077 | 0.030 |
Why?
|
| Blood Pressure | 3 | 2018 | 8543 | 0.030 |
Why?
|
| Walking | 1 | 2021 | 1201 | 0.030 |
Why?
|
| Quality of Life | 3 | 2021 | 13490 | 0.030 |
Why?
|
| Suture Techniques | 2 | 2009 | 775 | 0.030 |
Why?
|
| Recurrence | 1 | 2006 | 8509 | 0.030 |
Why?
|
| Comorbidity | 2 | 2020 | 10590 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2018 | 1667 | 0.030 |
Why?
|
| Mycoses | 1 | 2016 | 386 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2016 | 1375 | 0.030 |
Why?
|
| Antibodies | 1 | 2020 | 2421 | 0.020 |
Why?
|
| Myocytes, Cardiac | 2 | 2011 | 1682 | 0.020 |
Why?
|
| Young Adult | 4 | 2020 | 60066 | 0.020 |
Why?
|
| Contrast Media | 3 | 2010 | 5330 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2167 | 0.020 |
Why?
|
| Device Removal | 1 | 2016 | 643 | 0.020 |
Why?
|
| Streptococcus pneumoniae | 1 | 2016 | 764 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2021 | 54924 | 0.020 |
Why?
|
| Disease Models, Animal | 4 | 2009 | 18349 | 0.020 |
Why?
|
| Decorin | 1 | 2008 | 38 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 11095 | 0.020 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2008 | 81 | 0.020 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2016 | 1063 | 0.020 |
Why?
|
| Risk | 1 | 2020 | 9613 | 0.020 |
Why?
|
| Equipment Design | 1 | 2016 | 3522 | 0.020 |
Why?
|
| Pressure | 1 | 2011 | 1172 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2012 | 6283 | 0.020 |
Why?
|
| Elastin | 1 | 2008 | 299 | 0.020 |
Why?
|
| ROC Curve | 1 | 2015 | 3628 | 0.020 |
Why?
|
| Length of Stay | 1 | 2021 | 6498 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2008 | 527 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2011 | 703 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2016 | 1791 | 0.020 |
Why?
|
| Adolescent | 3 | 2020 | 89169 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 393 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2008 | 381 | 0.020 |
Why?
|
| Protein Binding | 1 | 2018 | 9343 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3252 | 0.020 |
Why?
|
| Cause of Death | 1 | 2016 | 3721 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2008 | 809 | 0.020 |
Why?
|
| Cardiotonic Agents | 1 | 2008 | 543 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2019 | 3288 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2016 | 2726 | 0.010 |
Why?
|
| Ventricular Function, Right | 1 | 2008 | 629 | 0.010 |
Why?
|
| Fluorescein Angiography | 1 | 2009 | 1086 | 0.010 |
Why?
|
| Sex Factors | 1 | 2017 | 10632 | 0.010 |
Why?
|
| Heart Atria | 1 | 2009 | 1361 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2016 | 41753 | 0.010 |
Why?
|
| Artifacts | 1 | 2011 | 1926 | 0.010 |
Why?
|
| Chronic Disease | 2 | 2008 | 9384 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2020 | 13053 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 2008 | 1617 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2014 | 3479 | 0.010 |
Why?
|
| Lung | 1 | 2019 | 10101 | 0.010 |
Why?
|
| Dopamine | 1 | 2008 | 1592 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2015 | 10478 | 0.010 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2008 | 1751 | 0.010 |
Why?
|
| United States | 2 | 2020 | 73039 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2008 | 4149 | 0.010 |
Why?
|
| Algorithms | 2 | 2011 | 14164 | 0.010 |
Why?
|
| Hospitalization | 1 | 2018 | 10840 | 0.010 |
Why?
|
| Inflammation | 1 | 2018 | 10873 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2009 | 5315 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2011 | 5107 | 0.010 |
Why?
|
| Heart Rate | 1 | 2008 | 4214 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 9016 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 20225 | 0.010 |
Why?
|
| Mice | 1 | 2018 | 82049 | 0.010 |
Why?
|
Concepts
(245)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_